RT @yvonnejudge: This. Now. @HSELive @SimonHarrisTD https://t.co/8f8WYGc8l8
RT @yvonnejudge: This. Now. @HSELive @SimonHarrisTD https://t.co/8f8WYGc8l8
RT @jessicagrehan: @yvonnejudge Sigh, feeling weary. Surely all cancer patients deserve a shot at prolonging life without having to fight t…
This. Now. @HSELive @SimonHarrisTD
RT @jessicagrehan: @yvonnejudge Sigh, feeling weary. Surely all cancer patients deserve a shot at prolonging life without having to fight t…
RT @jessicagrehan: @yvonnejudge Sigh, feeling weary. Surely all cancer patients deserve a shot at prolonging life without having to fight t…
RT @jessicagrehan: @yvonnejudge Sigh, feeling weary. Surely all cancer patients deserve a shot at prolonging life without having to fight t…
@yvonnejudge Sigh, feeling weary. Surely all cancer patients deserve a shot at prolonging life without having to fight this ongoing discrimination? There is SO much research lauding treat of NSCLC with Pembrolizumab regardless of PD-L1 https://t.co/RAz5A9G
ブライトパス:最近の肺非小細胞がんに対するキイトルーダを用いた治療レビュー。GRN-1201の併用治験も主要な進行中臨床試験でリストアップ(黄色地でマーク)。確かに進行がんに対し一次治療(最初の治療)としてのワクチン併用は数多くある併用療法治験の中でGRN-1201だけ。 https://t.co/7pkjjZExnH https://t.co/to5BcLUrlP